Bicara Therapeutics Inc. Common Stock (BCAX) — Financial Flexibility Index
Bicara Therapeutics Inc. Common Stock (BCAX) has a Financial Flexibility Index of -0.80x as of December 2025. Free cash flow of $-23.65 Million (operating CF $-23.89 Million minus capex $238.00K) represents -1% of total liabilities ($29.54 Million). Also explore Bicara Therapeutics Inc. Common Stock (BCAX) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bicara Therapeutics Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Bicara Therapeutics Inc. Common Stock across 4 annual periods. Check BCAX capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Bicara Therapeutics Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for Bicara Therapeutics Inc. Common Stock. For the full company profile including market capitalisation, see market cap of Bicara Therapeutics Inc. Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.61x | $-106.55 Million | $-106.83 Million | $29.54 Million | ▼ -273.4% |
| 2024 | -0.97x | $-74.68 Million | $-74.75 Million | $77.32 Million | ▲ +66.8% |
| 2023 | -2.91x | $-45.04 Million | $-45.63 Million | $15.47 Million | ▼ -118.9% |
| 2022 | -1.33x | $-31.88 Million | $-32.08 Million | $23.98 Million | — |